1-amino-2,4-dimethyl-pentan-3-one | 860546-41-4

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 1-amino-2,4-dimethyl-pentan-3-one
• 英文别名: 1-Amino-2,4-dimethyl-pentan-3-on；2-(Aminomethyl)-4-methyl-3-pentanone；1-amino-2,4-dimethylpentan-3-one
• CAS: 860546-41-4
• 化学式: C₇H₁₅NO
• 分子量: 129.202
• InChiKey: OOVMYITYEBRGIP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  9
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.86
• 拓扑面积：
  43.1
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  alkaline earth salt of/the/ methylsulfuric acid 在 甲醇 、 镍 作用下， 35.0 ℃ 、11.77 MPa 条件下， 生成 1-amino-2,4-dimethyl-pentan-3-one
  参考文献：
  名称：

  Wiley; Adkins, Journal of the American Chemical Society, 1938, vol. 60, p. 917

  摘要：

  DOI：

文献信息

• COMPOUNDS THAT TRAP ALPHA-OXOALDEHYDES AND ALPHA-BETA-UNSATURATED ALDEHYDES, META-COMPOUNDS CONTAINING SUCH COMPOUNDS, AND USE OF SAID COMPOUNDS IN TREATING ILLNESSES RELATED TO THE ACCUMULATION OF AGES AND ALES
  申请人：PHARMAMENS

  公开号：US20150038493A1

  公开（公告）日：2015-02-05

  The present invention relates to a series of molecules derived from 2,3-diaminopropionic acid (DAP), comprising or not comprising an 8-hydroxyquinoline (8-HQ) motif, and to the use of said molecules for trapping an alpha-oxoaldehyde resulting particularly from the degradation of the glucose or for trapping an alpha-beta-unsaturated aldehyde, resulting particularly from the oxidative degradation of fatty acids. These molecules can have a further application in the fields of cosmetics, food processing, and pharmaceuticals.

  本发明涉及一系列由2,3-二氨基丙酸（DAP）衍生的分子，包括或不包括8-羟基喹啉（8-HQ）基团，并且用于捕获尤其来自葡萄糖降解的α-酮醛或捕获尤其来自脂肪酸氧化降解的α-β-不饱和醛。这些分子还可以在化妆品、食品加工和制药领域中进一步应用。
• SUBSTITUTED PYRAZOLO[1,5-a] PYRIDINE COMPOUNDS AND THEIR METHODS OF USE
  申请人：Gaeta Federico C.A.

  公开号：US20090318437A1

  公开（公告）日：2009-12-24

  The present invention is directed to substituted pyrazolo[1,5-a]pyridines and related methods for their synthesis and use.

  本发明涉及取代的嘧唑并[1,5-a]吡啶及其合成和使用的相关方法。
• CHITOSAN-DERIVATIVE COMPOUNDS AND METHODS OF CONTROLLING MICROBIAL POPULATIONS
  申请人：Baker Shenda

  公开号：US20120329753A1

  公开（公告）日：2012-12-27

  The present invention is directed to chitosan-derivative compounds and structures, methods of making chitosan-derivative compounds and methods for controlling, inhibiting and enhancing microbial populations in a variety of environments. The present invention is also directed to the control, inhibition and enhancement of microbial populations in animals, particularly humans. The microbial populations include bacteria, viruses and other pathogens where control of microbial populations are a necessity. The chitosan-derivative compounds of the present invention include chitosan-arginine compounds, related chitosan-L/D unnatural amino acid compounds, chitosan-acid amine compounds, chitosan-L/D natural amino acid derivative compounds, co-derivatives of the chitosan-derivative compounds, salts of the chitosan derivative compounds, and chitosan-guanidine compounds.
• CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS
  申请人：Intellikine LLC

  公开号：US20190290636A1

  公开（公告）日：2019-09-26

  Chemical entities that modulate PI3 kinase activity, pharmaceutical compositions containing the chemical entities, and methods of using these chemical entities for treating diseases and conditions associated with PI3 kinase activity are described herein.
• US7585875B2
  申请人：——

  公开号：US7585875B2

  公开（公告）日：2009-09-08